Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Liuhong, Wu"'
Autor:
Yingxia Lan, Liuhong Wu, Jin Guo, Juan Wang, Huijie Guan, Baihui Li, Longzhen Liu, Lian Zhang, Ye Hong, Jun Deng, Jia Zhu, Suying Lu, Feifei Sun, Junting Huang, Xiaofei Sun, Yizhuo Zhang, Jian Wang, Ruiqing Cai
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-7 (2023)
Abstract The application of totally implantable access ports (TIAPs) reduces treatment-related discomfort; however, the existence of catheter may cause side effects, with the most common one being the occurrence of TIAPs-associated thrombosis. The ri
Externí odkaz:
https://doaj.org/article/7d7329f4c0e847bdb35bd73a7c7dca32
Autor:
Yingxia Lan, Liuhong Wu, Ye Hong, Xiaofei Sun, Juan Wang, Junting Huang, Feifei Sun, Jia Zhu, Zijun Zhen, Yizhuo Zhang, Mengjia Song, Suying Lu
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Metronomic maintenance therapy (MMT) has significantly improved the survival of patients with high-risk rhabdomyosarcoma in clinical trials. However, there remains a lack of relevant data on its effectiveness in real-world situations.Me
Externí odkaz:
https://doaj.org/article/b2fb7830c2ec493496e812594b02cd9c
The Efficacy and Safety of Anlotinib in Pediatric Patients With Refractory or Recurrent Solid Tumors
Autor:
Suying Lu, Ye Hong, Huimou Chen, Liuhong Wu, Feifei Sun, Juan Wang, Jia Zhu, Yi Que, Lian Zhang, Zijun Zhen, Xiaofei Sun, Junting Huang, Yizhuo Zhang
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Objective: Refractory or recurrent pediatric solid tumors lack effective treatments, and are associated with dismal outcomes. Hence, there is an urgent need for a novel therapeutic strategy. This study aimed to evaluate the efficacy and safety of anl
Externí odkaz:
https://doaj.org/article/e2b6278675ff447b982de353119692fa
Autor:
Juan Wang, Lian Zhang, Lanying Guo, Yi Que, Yu Zhang, Feifei Sun, Jia Zhu, Suying Lu, Junting Huang, Liuhong Wu, Ruiqing Cai, Zijun Zhen, Sihui Zeng, Yizhuo Zhang, Xiaofei Sun
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
PurposeThe prognosis of relapsed or refractory pediatric Wilms tumor (WT) is dismal, and new salvage therapies are needed. This study aimed to evaluate the efficacy of the combination of irinotecan and a doxorubicin hydrochloride liposome regimen for
Externí odkaz:
https://doaj.org/article/c8d5b500c0124ca29c8a730b1e9a222d
Autor:
Jia Zhu, Chengtao Sun, Chao Zhang, Wei Li, Feifei Sun, Xing Zhang, Zijun Zhen, Juan Wang, Junting Huang, Yizhuo Zhang, Xiaofei Sun, Ruiqing Cai, Liuhong Wu, Huimou Chen, Suying Lu
Publikováno v:
Cancer Management and Research. 12:12123-12136
Purpose The goal of the current study was to identify potential prognostic biomarkers of rhabdomyosarcoma (RMS). Materials and Methods We screened chip sequencing datasets of RMS through the gene expression omnibus (GEO) database. A total of 74 RMS p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d50e79ad6498d69199c58152b6c075c
https://doi.org/10.2147/cmar.s265779
https://doi.org/10.2147/cmar.s265779
Autor:
Xiaofei Sun, Yizhuo Zhang, Ruiqing Cai, Hui Li, Yu Zhang, Suying Lu, Feifei Sun, Zijun Zhen, Jia Zhu, Liuhong Wu, Juan Wang, Junting Huang, Meiling Liu
Publikováno v:
Cancer Management and Research. 12:6177-6185
Background The prognosis of recurrent or refractory advanced childhood solid tumor patients is very poor and new therapeutic strategies are in urgent need. This study aimed to determine the efficacy and safety of apatinib in pediatric refractory/rela
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0718062967f3012a85a64ebac9ba5752
https://doi.org/10.2147/cmar.s258689
https://doi.org/10.2147/cmar.s258689
Autor:
Lanying Guo, Liuhong Wu, Yu Zhang, Yizhuo Zhang, Sihui Zeng, Yi Que, Xiaofei Sun, Juan Wang, Lian Zhang, Suying Lu, Ruiqing Cai, Zijun Zhen, Junting Huang, Feifei Sun, Jia Zhu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
PurposeThe prognosis of relapsed or refractory pediatric Wilms tumor (WT) is dismal, and new salvage therapies are needed. This study aimed to evaluate the efficacy of the combination of irinotecan and a doxorubicin hydrochloride liposome regimen for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b461b9c5457b5f61b32d9aba4d6ac68
The Efficacy and Safety of Anlotinib in Pediatric Patients With Refractory or Recurrent Solid Tumors
Autor:
Suying Lu, Ye Hong, Huimou Chen, Liuhong Wu, Feifei Sun, Juan Wang, Jia Zhu, Yi Que, Lian Zhang, Zijun Zhen, Xiaofei Sun, Junting Huang, Yizhuo Zhang
Publikováno v:
Frontiers in pharmacology. 13
Objective: Refractory or recurrent pediatric solid tumors lack effective treatments, and are associated with dismal outcomes. Hence, there is an urgent need for a novel therapeutic strategy. This study aimed to evaluate the efficacy and safety of anl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffbf580b88991b275864f287537567ed
https://pubmed.ncbi.nlm.nih.gov/35431969
https://pubmed.ncbi.nlm.nih.gov/35431969
Autor:
Feifei, Sun, Suying, Lu, Zijun, Zhen, Jia, Zhu, Juan, Wang, Junting, Huang, Yu, Zhang, Hui, Li, Ruiqing, Cai, Meiling, Liu, Liuhong, Wu, Xiaofei, Sun, Yizhuo, Zhang
Publikováno v:
Cancer Management and Research
Background The prognosis of recurrent or refractory advanced childhood solid tumor patients is very poor and new therapeutic strategies are in urgent need. This study aimed to determine the efficacy and safety of apatinib in pediatric refractory/rela
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::880eefb3a982db9b068dd2b4e2f5bb21
https://pubmed.ncbi.nlm.nih.gov/32801866
https://pubmed.ncbi.nlm.nih.gov/32801866
Autor:
Feifei Sun, Zijun Zhen, Yizhuo Zhang, Junting Huang, Liuhong Wu, Lian Zhang, Juan Wang, Suying Lu, Jia Zhu, Ruiqing Cai, Yi Que, Xiaofei Sun
Publikováno v:
Journal of Clinical Oncology. 39:e22007-e22007
e22007 Background: To evaluate the efficacy of the regimen of combination of irinotecan and doxorubicin hydrochloride liposome in relapsed/refractory pediatric Wilms’ tumor. Life quality and toxicity are seriously considered and assessed. Methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e83a198c84889d9398d1d3918a4796b
https://doi.org/10.1200/jco.2021.39.15_suppl.e22007
https://doi.org/10.1200/jco.2021.39.15_suppl.e22007